Overview

Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With Dementia

Status:
Completed
Trial end date:
2017-11-01
Target enrollment:
Participant gender:
Summary
This study seeks to evaluate the effect of intepirdine (RVT-101) on gait and balance in patients with Alzheimer's Disease, Dementia with Lewy Bodies or Parkinson's Disease Dementia.
Phase:
Phase 2
Details
Lead Sponsor:
Axovant Sciences Ltd.